Dow Up 0.12% Nasdaq Up 1.35%

Janus Global Life Sciences T (JAGLX)

50.67 Up 0.61(1.22%) Oct 20
Prev Close:50.06
YTD Return*:21.99%
Net Assets*:2.58B
Yield*:N/A

* As of 30-Sep-14

Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for JAGLX at this time.

Top Holdings

Symbol% AssetsYTD Return %
GILD4.0240.60
CELG2.7510.59
AET2.6017.36
JNJ2.5016.13
BIIB2.4515.71

Fund Basics

Morningstar Overall Rating:
Total Assets:2.58B
Category:Health
Annual Report Expense Ratio (net):0.94%

Performance & Risk

YTD Return:21.99%
5y Avg Return:23.78%
Rank in Category (ytd):6
% Rank in Category (ytd):4.76%
Beta (3y):0.64
Morningstar Risk Rating:3

Fund Summary

The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback